NOVEN ANNOUNCES SECOND QUARTER EARNINGS RELEASE DATE

Back

Miami, FL, August 1, 2006 -- Noven Pharmaceuticals, Inc. (NASDAQ: NOVN) today announced its second quarter 2006 earnings release date.

On August 9, before the U.S. market opens, Noven is scheduled to issue a press release announcing its financial results for the quarter ended June 30, 2006. At 9:00 a.m. Eastern Time the same day, a conference call among management and analysts will be broadcast live via the Internet at www.noven.com, and thereafter a rebroadcast will be accessible at the same site for at least two weeks. A taped replay of the call will be available beginning the afternoon of August 9 through August 11 by calling 877-660-6853 (from within the U.S.) or 201-612-7415 (from outside the U.S.) and entering account number 286 and conference ID number 207627.

Noven Pharmaceuticals, Inc., headquartered in Miami, Florida, is a leading developer of advanced transdermal drug delivery technologies and prescription transdermal products. Noven’s prescription patches are approved in over 30 countries and include Vivelle-Dot™ (the most prescribed estrogen patch in the U.S.) and Daytrana™ (the first and only patch approved for the treatment of ADHD). A range of new patches is being investigated and developed in collaboration with Shire plc, P&G Pharmaceuticals, Endo Pharmaceuticals Inc. and others. Noven is committed to expanding the universe of available transdermal therapies for the benefit of patients, partners and shareholders. See www.noven.com for additional information.

Back

Copyright © 2006 Noven Pharmaceuticals, Inc. All rights reserved.